Description: Through a collaboration spanning Ludwig Cancer Centers and Branches in multiple countries, we are studying how interactions among tumor and immune cells regulate the initiation and development of cancer and how cancer therapy can be optimized for individual patients.
Through a collaboration spanning Ludwig Cancer Centers and Branches in multiple countries, we are studying how interactions among tumor and immune cells regulate the initiation and development of cancer and how cancer therapy can be optimized for individual patients.
BRCA1-Associated Triple Negative Breast Cancer
Combination Therapy in Ovarian Cancer